Neurology clinical trials recruiting in Illinois

104 recruiting neurology trials match in Illinois. Showing 20.

• A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's DiseaseRecruiting

  Phase 3 · Hoffmann-La Roche · Chicago, Illinois

• A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet SyndromeRecruiting

  Phase 3 · Epygenix · Birmingham, Alabama

• A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)Recruiting

  Phase 3 · Merck Sharp & Dohme LLC · Chicago, Illinois

• Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR VariantRecruiting

  Phase 3 · Eidos Therapeutics, a BridgeBio company · Chicago, Illinois

• Non-invasive VNS for Parkinson's GaitRecruiting

  N/A · VA Office of Research and Development · Hines, Illinois

• People With Multiple Sclerosis Treated With Ocrelizumab and GLP-1 AgonistsRecruiting

  N/A · Northwestern University · Chicago, Illinois

• Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.Recruiting

  Phase 3 · Novartis Pharmaceuticals · Chicago, Illinois

• Feasibility of Using the Gatorade Sports Science Institute (GSSI) Labs App for Hydration Related OutcomesRecruiting

  N/A · PepsiCo Global R&D · Chicago, Illinois

• A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of MigraineRecruiting

  Phase 3 · Kallyope Inc. · Chicago, Illinois

• A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's DiseaseRecruiting

  Phase 2 / Phase 3 · Biohaven Therapeutics Ltd. · Chicago, Illinois

• A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)Recruiting

  Phase 3 · Merck Sharp & Dohme LLC · Chicago, Illinois

• A Digital Therapeutic Platform for Swallowing and Drooling Problems in Parkinson'sRecruiting

  Phase 3 · Northwestern University · Evanston, Illinois

• RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical IllnessesRecruiting

  Phase 2 · Reunion Neuroscience Inc · Chicago, Illinois

• Evaluation of the Safety and Efficacy of a Full-Body Electrostimulation Garment for Individuals With Neurological and Neuromuscular Conditions That Cause Spasticity, Hyperreflexia, and PainRecruiting

  N/A · Shirley Ryan AbilityLab · Chicago, Illinois

• Wearable Biofeedback for Swallowing Disorders Rehabilitation in Stroke and Parkinson DiseaseRecruiting

  Phase 2 · University of Illinois at Urbana-Champaign · West Lafayette, Indiana

• Effects of Acute Intermittent Hypoxia on Neuroplasticity in MSRecruiting

  N/A · Shirley Ryan AbilityLab · Chicago, Illinois

• Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS RegistryRecruiting

  N/A · Boston Scientific Corporation · Chicago, Illinois

• A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)Recruiting

  N/A · TG Therapeutics, Inc. · Chicago, Illinois

• Ublituximab (Briumvi) for Early Forms of Relapsing Multiple SclerosisRecruiting

  Phase 4 · Northwestern University · Chicago, Illinois

• A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of MigraineRecruiting

  Phase 3 · Kallyope Inc. · Chicago, Illinois

Source: ClinicalTrials.gov. Recruitment status changes often — confirm on each study page.